{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T06:33:31Z","timestamp":1771655611937,"version":"3.50.1"},"reference-count":0,"publisher":"Clinical and Experimental Rheumatology","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.55563\/clinexprheumatol\/tdp7to","type":"journal-article","created":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T16:32:05Z","timestamp":1649176325000},"source":"Crossref","is-referenced-by-count":1,"title":["The erratic C-reactive protein: a novel outcome measure for longitudinal disease activity in rheumatoid arthritis"],"prefix":"10.55563","author":[{"given":"Andrew E.","family":"Thompson","sequence":"first","affiliation":[{"name":"The Arva Clinic, Arva, Ontario, Canada. andy@arvaclinic.com"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet E.","family":"Pope","sequence":"additional","affiliation":[{"name":"Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"34330","published-online":{"date-parts":[[2021,5,21]]},"container-title":["Clinical and Experimental Rheumatology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T16:32:05Z","timestamp":1649176325000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.clinexprheumatol.org\/abstract.asp?a=17449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,21]]},"references-count":0,"alternative-id":["CER14822","34596032"],"URL":"https:\/\/doi.org\/10.55563\/clinexprheumatol\/tdp7to","relation":{},"ISSN":["1593-098X"],"issn-type":[{"value":"1593-098X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,21]]}}}